David Einhorn - Greenlight Capital
EDGAR CIK 1489933 ↗ · Waiting · typical filing lag 45 days · EDGAR name DME Capital Management, LP (Greenlight Capital, David Einhorn); Greenlight Capital Inc (1079114) last 13F 2024-02-14
| Security | Weight | Δ wt | Price* | Shares | Δ shares | Value | Action | |
|---|---|---|---|---|---|---|---|---|
| 1 | GRBK GREEN BRICK PARTNERS INC | 32.91% | +3.6% | $84 | 9.47M | -9.6% | $791M | Trimmed |
| 2 | — CONSOL ENERGY INC NEW | 7.15% | -1.0% | $105 | 1.64M | +0.0% | $172M | Held |
| 3 | BHF BRIGHTHOUSE FINL INC | 5.42% | -0.9% | $45 | 2.89M | -2.7% | $130M | Trimmed |
| 4 | HPQ HP INC | 5.27% | -0.5% | $36 | 3.53M | +4.7% | $127M | Added |
| 5 | KD KYNDRYL HLDGS INC | 4.71% | -1.0% | $23 | 4.92M | +11.0% | $113M | Added |
| 6 | PENN PENN ENTERTAINMENT INC | 4.41% | -0.4% | $19 | 5.62M | +10.3% | $106M | Added |
| 7 | — LIBERTY GLOBAL LTD | 3.74% | +2.0% | $21 | 4.25M | +108.3% | $89.78M | Added |
| 8 | ALITEUR ALIGHT INC | 3.65% | -0.3% | $7 | 11.85M | +7.0% | $87.66M | Added |
| 9 | VTRS VIATRIS INC | 3.51% | -0.3% | $12 | 7.27M | -1.7% | $84.41M | Trimmed |
| 10 | — CNH INDL N V | 3.28% | +3.3% | $11 | 7.10M | new | $78.78M | New |
| 11 | — ROIVANT SCIENCES LTD | 2.55% | +0.1% | $12 | 5.31M | +10.3% | $61.25M | Added |
| 12 | TECK TECK RESOURCES LTD | 2.36% | -0.2% | $52 | 1.09M | +0.0% | $56.77M | Held |
| 13 | GLD SPDR GOLD TR | 2.11% | -0.0% | $243 | 209K | +3.1% | $50.72M | Added |
| 14 | — DHT HOLDINGS INC | 1.99% | -0.3% | $11 | 4.34M | +7.9% | $47.91M | Added |
| 15 | THC TENET HEALTHCARE CORP | 1.99% | -1.9% | $166 | 287K | -52.0% | $47.72M | Trimmed |
| 16 | ODP1 THE ODP CORP | 1.98% | -2.3% | $30 | 1.60M | -28.0% | $47.60M | Trimmed |
| 17 | — CAPRI HOLDINGS LIMITED | 1.92% | +0.8% | $42 | 1.09M | +58.7% | $46.12M | Added |
| 18 | PTON PELOTON INTERACTIVE INC | 1.86% | +0.7% | $5 | 9.53M | +40.4% | $44.60M | Added |
| 19 | PPLI IAC INC | 1.43% | +0.8% | $54 | 636K | +118.3% | $34.24M | Added |
| 20 | — LIVANOVA PLC | 1.32% | -0.4% | $53 | 604K | -6.3% | $31.71M | Trimmed |
| 21 | GPK GRAPHIC PACKAGING HLDG CO | 1.29% | -0.5% | $30 | 1.05M | -25.0% | $30.98M | Trimmed |
| 22 | — SEADRILL 2021 LTD | 0.99% | -0.4% | $40 | 602K | +5.6% | $23.91M | Added |
| 23 | PPA INVESCO EXCHANGE TRADED FD T | 0.87% | -0.0% | $115 | 183K | +0.0% | $20.98M | Held |
| 24 | XAR SPDR SER TR | 0.84% | -0.0% | $157 | 128K | +0.0% | $20.07M | Held |
| 25 | — WEATHERFORD INTL PLC | 0.63% | -0.4% | $85 | 177K | +0.0% | $15.06M | Held |
| 26 | LKFT GALAPAGOS NV | 0.57% | +0.3% | $29 | 479K | +104.1% | $13.80M | Added |
| 27 | COYA COYA THERAPEUTICS INC | 0.34% | -0.0% | $6 | 1.27M | +0.0% | $8.22M | Held |
| 28 | TEVAN TEVA PHARMACEUTICAL INDS LTD | 0.24% | -0.0% | $18 | 325K | +0.0% | $5.85M | Held |
| 29 | GDX VANECK ETF TRUST | 0.18% | -0.0% | $40 | 111K | +0.0% | $4.44M | Held |
| 30 | GPRO GOPRO INC | 0.16% | -0.0% | $1 | 2.82M | +0.0% | $3.84M | Held |
| 31 | OIH VANECK ETF TRUST | 0.13% | -0.0% | $284 | 11K | +0.0% | $3.18M | Held |
| 32 | FCG FIRST TR EXCHANGE-TRADED FD | 0.07% | -0.0% | $24 | 71K | +0.0% | $1.68M | Held |
| 33 | PDBC INVESCO ACTVELY MNGD ETC FD | 0.07% | -0.0% | $13 | 117K | +0.0% | $1.58M | Held |
| 34 | GANX GAIN THERAPEUTICS INC | 0.04% | +0.0% | $2 | 566K | +0.0% | $1.01M | Held |
| 35 | — DANIMER SCIENTIFIC INC | 0.02% | -0.1% | $0 | 1.10M | -59.9% | $498K | Trimmed |
| 36 | NUVB NUVATION BIO INC | 0.00% | -0.0% | $2 | 35K | +0.0% | $80.14K | Held |
| 37 | NUVB/WS NUVATION BIO INC | 0.00% | -0.0% | $0 | 100K | +0.0% | $9.79K | Held |
| 38 | — KATAPULT HOLDINGS INC | 0.00% | -0.0% | $0 | 262K | +0.0% | $1.50K | Held |
| 39 | SHC SOTERA HEALTH CO | 0.00% | -0.2% | — | 0 | 300K → 0 | $0 | Exited |
| 40 | — TALIS BIOMEDICAL CORP | 0.00% | -0.1% | — | 0 | 149K → 0 | $0 | Exited |
* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.
| Quarter | Period end | Reported value | Positions | Largest | New | Exited | Filed | Lag |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.91B | 46 | 19.4% | 7 | 6 | 14 Aug 2026 ET | 45 |
| Q1 2026 | 2026-03-31 | $3.19B | 45 | 19.1% | 11 | 7 | 15 May 2026 ET | 45 |
| Q4 2025 | 2025-12-31 | $2.85B | 41 | 20.8% | 8 | 4 | 17 Feb 2026 ET | 48 |
| Q3 2025 | 2025-09-30 | $2.54B | 37 | 27.5% | 4 | 1 | 14 Nov 2025 ET | 45 |
| Q2 2025 | 2025-06-30 | $2.33B | 34 | 25.6% | 4 | 3 | 14 Aug 2025 ET | 45 |
| Q1 2025 | 2025-03-31 | $1.97B | 33 | 28.0% | 2 | 5 | 15 May 2025 ET | 45 |
| Q4 2024 | 2024-12-31 | $1.94B | 36 | 27.5% | 5 | 7 | 14 Feb 2025 ET | 45 |
| Q3 2024 | 2024-09-30 | $2.40B | 38 | 32.9% | 1 | 2 | 14 Nov 2024 ET | 45 |
| Q2 2024 | 2024-06-30 | $2.04B | 39 | 29.3% | 3 | 6 | 14 Aug 2024 ET | 45 |
| Q1 2024 | 2024-03-31 | $2.18B | 42 | 28.9% | — | — | 15 May 2024 ET | 45 |
| Quarter | Book | S&P 500 | Excess | Coverage | Best call |
|---|---|---|---|---|---|
| Q2 2026 | -8.3% | -4.1% | -4.1% | 85% | ACHC +24.7% |
| Q1 2026 | +5.5% | +0.9% | +4.5% | 86% | VSXY +119.9% |
| Q4 2025 | +2.0% | +9.6% | -7.6% | 80% | CNC +81.4% |
| Q3 2025 | +5.2% | +11.7% | -6.5% | 81% | VSXY +183.2% |
| Q2 2025 | +4.5% | +16.7% | -12.2% | 78% | CNC +177.8% |
| Q1 2025 | +4.0% | +27.8% | -23.8% | 78% | VTRS +150.4% |
| Q4 2024 | -5.6% | +24.1% | -29.7% | 71% | VTRS +106.4% |
| Q3 2024 | -4.4% | +28.0% | -32.4% | 71% | VTRS +78.2% |
| Q2 2024 | +6.1% | +40.1% | -34.0% | 71% | VTRS +99.3% |
| Q1 2024 | +10.0% | +44.3% | -34.2% | 70% | THC +118.7% |
Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.